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In this report we examined the antigen-presenting cell (APC) requirements for activation of 
T-cell hybridomas specific for the protein antigen PPD (purified protein derivative of tuberculin). 
During the course of these studies we observed that glutaraldehyde fixation of la-positive A20.2JAD 
(A20) and P388Dl stimulator cells had different effects on T-cell activation. A20 cells fixed with 
glutaraldehyde stimulated the T cells in the presence of PPD as efficiently as nonfixed A20 cells. 
By contrast, glutaraldehyde treatment of Ia-positive P388Dl cells dramatically inhibited their 
ability to process and/or present PPD to T cells. This was not due to nonspecific effects on the 
P388Dl cells since cells prepulsed with PPD prior to glutaraldehyde treatment stimulated T cells 
as efficiently as non-glutaraldehyde-treated P388Dl cells. In addition, there was no apparent 
difference in “fixing” of the two cell types as determined by the uptake of radiolabeled thymidine. 
These observations suggested that P388D1, but not A20, cells required PPD internalization to 
form the relevant antigenic determinants. This was substantiated by showing that treatment of 
P388Dl cells with chloroquine prior to PPD pulsing eliminated their stimulatory capacity, but 
had no effect on P388DI cells previously pulsed with PPD. Chloroquine treatment had no effect 
on stimulation by A20 cells. Since PPD internalization appeared not to be required for presentation 
by A20 cells, we next determined if isolated A20 plasma membranes would substitute for the 
intact cell. We observed that the isolated plasma membranes from PPD-pulsed A20 cells stimulated 
the T hybridoma cells, and that this stimulation was antigen-specific and was inhibited by anti- 
Ia monoclonal antibodies. Taken together, the results presented here suggest that for the PPD- 
specific T-cell responses examined here, different APC utilize distinct pathways to present the 
same antigenic determinant for T-cell recognition. 0 1985 Academic press, IN. 
INTRODUCTION 
The mechanism(s) by which antigen-presenting cells (APC)* form antigenic deter- 
minants from foreign antigens that are recognized by T cells has generally been called 
antigen processing or antigen handling. This mechanism is only beginning to be elu- 
cidated, and seems to involve several elements. For larger proteins, one initial event 
appears to be antigen internalization and subsequent catabolism to smaller peptide 
’ This work was supported by U.S. Public Health Service Grant AI-19273 from the National Institute of 
Allergy and Infectious Diseases. 
* Abbreviations used: APC, antigen-presenting cells; CAS, culture supematant fluid from concanavalin 
A activated spleen cells; K-2, interleukin 2; HBSS, Hanks’ balanced salt solution; PPD, purified protein 
derivative of tuberculin; PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride. 
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fragments, which form the antigen actually recognized by T cells (l-5). These results 
are based primarily on experiments in which agents that inhibit lysosomal proteolysis 
block formation of the relevant antigen, and on fixing the APC with glutaraldehyde 
or paraformaldehyde to prevent antigen internalization and formation of the antigenic 
fragment. If smaller hapten or peptide antigens are used, then there seems to be no 
requirement for internalization and fixed APC present antigen as efficiently as untreated 
APC ( 1,2,6). In the case of small peptide antigens, APC membrane structures associate 
with the peptides and retain the antigen to be utilized in T-cell responses (7). It has 
been assumed that the antigen recognized by T cells is associated with the APC mem- 
brane, and that isolated membranes from antigen-pulsed APC provide a source of 
antigen for T-cell responses (2,7). However, T-cell stimulation with isolated membranes 
has generally required additional APC, suggesting that the membranes are processed 
and the antigen presented only in the context of the APC, and that it is not direct T- 
cell recognition of the membrane-associated antigen t(2); unpublished observations]. 
In this report we have examined the effects of glutaralydehyde treatment on pre- 
sentation of protein antigen to the same murine T-cell hybridoma by different APC. 
It was found that presentation of the same antigen to the same T cells by two different 
APC showed a dramatic difference in the effects of glutaraldehyde fixation and chlo- 
roquine treatment. These results suggest that proteolytic processing enzymes may 
have different cellular locations in different APC, and/or that APC may have unique 
mechanisms for antigen handling. In addition, it is also shown that isolated membranes 
from PPD-pulsed A20 specifically activate T-cell hybridomas in the absence of ad- 
ditional APC, thus providing direct evidence that the APC events involved in T-cell 
recognition are all membrane-associated and do not require intact cells. 
MATERIALS AND METHODS 
T-Cell Hybridomas 
T-Cell hybridomas were prepared as described elsewhere (8, 9). Briefly, Bab. 14 
(H-8 mice were immunized with complete Freund’s adjuvant (Difco Laboratories, 
Detroit, Mich.), and the popliteal lymph nodes were removed 2 weeks later. The 
lymph node cells were cultured with 50 pg/ml PPD (Connaught Medical Research 
Labs, Ontario, Canada) at 2.5 X lo6 cells/ml in RPM1 1640 medium (M.A. Bioprod- 
ucts, Walkersville, Md.) containing 300 pg/ml glutamine (KC Biological, Lenexa, 
Kans.), 5 X lop5 A4 2-mercaptoethanol (Bio-Rad Laboratories, Richmond, Calif.), 
and 10% heat inactivated fetal calf serum (Hyclone Laboratories, Logan, Utah) for 3 
days, and the blast cells were harvested by centrifugation on Ficoll-Hypaque (Sigma 
Chemical Co., St. Louis, MO.). The blasts were cultured for an additional 2 days at 1 
to 2 X lo5 cells/ml in medium containing 25% supematant fluid from concanavalin 
A (Con A, Miles-Yeda International, Elkhart, Ind.)-stimulated rat spleen cells (CAS) 
and 0.1% a-methylmannoside (Sigma Chemical Co.). The resulting blast cells were 
fused with BW5147 cells (a generous gift from Dr. Ethan Shevach, Laboratory of 
Immunology, NIH) by established procedures (8, 9). 
The resulting hybridomas were screened with Balb/c spleen cells and 50 pg/ml PPD 
for IL-2 production as described below. Those hybrids that showed PPD-specific 
IL-2 production were further subcloned by limiting dilution. The PPD-specific T hy- 
bridomas showed genetic restrictions for I-Ad and stimulation could be specifically 
blocked by anti-lad monoclonal antibodies, such as M5/114.15.2 (American Type 
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Culture Collection, Rockville, Md.). The T-cell hybridomas were maintained in Dul- 
becco’s modified Eagle medium (M.A. Bioproducts, Walkersville, Md.) containing 
glutamine, penicillin-streptomycin, 2-mercaptoethanol, 10% nutrient cocktail (lo), 
hypoxanthine, aminopterin, thymidine, and 15% heat-inactivated FCS. 
Antigen-Presenting Cell Treatment 
APC used in these experiments were the Iad-positive B-cell lines A20.2JAD (a gen- 
erous gift from Dr. Philippa Marrack, National Jewish Hospital, Denver, Colo.) and 
the macrophage-like cell line P388Dl (from Dr. P. Marrack). The P388Dl were in- 
duced to express Iad antigens as described before (11) by culture for 2 days in 25% 
supernatant fluid from ConA-stimulated rat spleen cells (CAS) and 0.1% cu-methyl- 
mannoside. Uninduced P388Dl showed some Ia expression by radioimmunoassay 
which was increased 5- to lo-fold after induction with CAS. Antigen-pulsed A20 or 
Ia-positive P388Dl cells were prepared by 2-hr culture in the presence of PPD at 200 
pg/ml, and by washing them three times with Hanks’ balanced salt solution (HBSS) 
to remove free PPD. 
For glutaraldehyde fixation, cells were washed in phosphate-buffered saline (PBS, 
pH 7.2) and treated by mixing for 15 set with glutaraldehyde (Sigma Chemical Co.) 
in desired concentrations in PBS. The reaction was terminated by addition of excess 
PBS containing 0.1% glycine (Sigma Chemical Co.), and the cells were washed three 
times in HBSS prior to being used as APC. For chloroquine treatment, Ia-positive 
APC were treated with 600 PLM chloroquine for 45 min at 37°C either before or after 
PPD pulsing, as described elsewhere ( 12). 
Preparation of Plasma Membranes from Antigen-Presenting Cells 
The A20 cells from which the plasma membranes were isolated, either untreated 
or pulsed overnight with PPD (200 pg/ml), were washed three times with HBSS and 
resuspended in HBSS containing 10 pg/ml of phenylmethylsulfonyl fluoride (PMSF, 
Sigma Chemical Co.). The cells were disrupted in a cell disrupter (Stansted Fluid 
Power Ltd., Essex, England), using an aperture setting that sheared only the plasma 
membranes from the surface of the cell while leaving the nucleus and much of the 
cytoplasm intact. The sheared cells were centrifuged at 1500 rpm for 10 min at 4°C 
to remove nuclei and cells, and then the supernatant fluid was centrifuged at 5500 
rpm for 15 min in a Sorvall RC-2B centrifuge at 4°C to remove subcellar organelles. 
The supernatant fluid from the 5500~rpm centrifugation was collected and centrifuged 
again at 16,000 rpm for 40 min at 4°C and the resulting crude plasma membrane 
pellet was resuspended in sterile PBS and stored at -70°C until used. 
T-Cell Stimulation Culture and Assay for Interleukin 2 Production 
PPD-specific T hybridoma cells (2 X lo5 cells/well) were cultured with 1 X lo5 Ia- 
positive P388Dl cells or 2 X lo5 A20.2JAD cells in hybridoma maintenance medium. 
No antigen or 10 pg/well of soluble PPD was added to the cultures. After 20 hr of 
culture the supernatant fluid was removed and assayed for interleukin 2 (IL-2) with 
IL-2 dependent HT-2 cells (a generous gift from Dr. Ethan Shevach) as described 
elsewhere (8,9, 13). The greatest dilution of supernatant fluid maintaining >90% HT- 
2 viability was the end point scored and the results were expressed as IL-2 units/ml. 
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RESULTS 
During the course of our studies on antigen processing and presentation by APC 
cells for T-cell activation, we noticed that Ia-positive A20.2JAD (A20) and P388Dl 
cells showed a differential sensitivity to glutaraldehyde fixation. Ia-positive P388Dl 
cells fixed with glutaraldehyde in concentrations higher than 0.025% did not stimulate 
PPD-specific T hybridoma cells in the presence of soluble PPD (Table l), and the 
T cells were stimulated only slightly by P388Dl cells fixed with 0.0 125% glutaraldehyde. 
On the other hand, A20 cells remained active in stimulating T hybridomas in the 
presence of PPD even though the cells were fixed with glutaraldehyde at concentrations 
of up to 0.05% (Table 1). One implication of these results is that A20 cells do not 
require PPD internalization for processing, or that antigen presentation may not require 
any processing event to present PPD to T hybridomas. A less likely possibility may 
be that the A20 cells might not be fixed efficiently enough to block uptake of PPD, 
despite other published reports to the contrary (1). To examine this, A20 and P388Dl 
cells were fixed with glutaraldehyde at varying concentrations and examined for their 
capability to take up extracellular materials from the medium using [‘Hlthymidine. 
As shown in Table 2, fixation with glutaraldehyde in concentrations of 0.0125% or 
higher blocked the uptake of [‘Hlthymidine efficiently (>95%) in A20 cells as well as 
P388Dl cells. 
Another possibility to be considered is that the failure to stimulate T hybridomas 
by P388Dl cells fixed with glutaraldehyde might result from damage to other surface 
structures of the cells involved in stimulation, rather than direct interference with 
antigen processing. To examine this, we prepared Ia-positive P388Dl cells pulsed with 
PPD prior to and after fixing with glutaraldehyde to determine the nonspecific effects 
of glutaraldehyde on stimulation. The results shown in Table 3 clearly indicate that 
PPD-pulsed P388Dl were not sensitive to subsequent glutaraldehyde fixation, and 
were able to stimulate T hybridomas. To rule out the possibility that glutaraldehyde 
TABLE 1 
Ability of Glutaraldehyde Fixed Antigen-Presenting Cells to Stimulate 




Stimulator cell type 
Ia-positive P388DI b 
0 (no antigen) <20 <20 
0 160 320 
0.0125 320 80 
0.025 320 <20 
0.0375 320 <20 
0.05 160 <20 
a Ia-positive P388Dl or A20.2JAD cells were treated with glutaraldehyde at the concentration indicated, 
and then added to culture with 10 &well PPD for stimulation of PPD-specific T hybridomas. 
b P388DI cells were induced for Ia expression by culture for a day in CAS. 
’ Units per milliliter of IL-2 contained in the culture supematant fluids of each culture were determined 
as described under Materials and Methods. IL-2 activity in culture without antigen was less than 20 
units/ml. 
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TABLE 2 











15,996 f  2681 
612 + 251 
530 + 367 
730 + 361 
452 f  81 
la-positive 
P388DI 
14,349 f  1612 
414 f  261 
212 2 78 
257 k 12 
17+ 24 
a Cells were treated with glutaraldehyde as described under Materials and Methods. 
b Glutaraldehyde-fixed or intact cells were incubated with I &i of [‘Hlthymidine for 4 hr at 37°C. Cells 
were harvested by an automatic cell harvester, and the cell-bound counts per minute were determined. 
Each value represents the average counts per minute and standard error from triplicate cultures. 
only makes processing less efficient on Ia-positive P388Dl cells, we determined if 
increasing the amount of PPD overcomes the inhibition caused by glutaraldehyde 
treatment. It was observed, however, that increasing the PPD concentration up to 
2 mg/ml failed to stimulate in the presence ofglutaraldehyde-treated Ia-positive P388Dl 
cells. In addition, increasing the concentration of glutaraldehyde-treated P388Dl cells 
to 1 X 1 06/well also did not result in T-cell stimulation, ruling out that glutaraldehyde- 
induced inhibition could be overcome by adding more cells (data not shown). 
Based on the above results, the most likely explanation for these results is that 
P388D1, but not A20, cells internalize the PPD to form the relevant antigenic deter- 
TABLE 3 
Stimulation of T Hybridoma Cells by Ia-Positive P388Dl Cells Fixed with Glutamldehyde 
before or after Exposure to PPD 
IL-2 units/ml 







0 640 640 
0.0125 20 320 
0.025 <20 320 
0.0375 <20 320 
0.05 <20 160 
“CAS-induced la-positive P388DI cells were fixed with glutaraldehyde in the concentration of 0 to 
0.05%, and then incubated with 200 pg/ml PPD for 2 hr at 37°C washed, and added to T hybridoma for 
stimulation. 
b CAS-induced Ia-positive P388DI cells were incubated with 200 &ml PPD for 2 hr at 37°C washed, 
and then fixed with glutaraldehyde in the concentration of 0 to 0.05%, and added to T hybridoma for 
stimulation. 
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minant. Other studies have indicated that this internalization is required for lysosomal 
catabolism and that antigen processing can be blocked by reagents such as chloroquine. 
As shown in Table 4, chloroquine treatment of Ia-positive P388Dl cells before PPD 
pulsing dramatically interfered with stimulation, whereas treatment after PPD pulsing 
had little inhibitory effect. Chloroquine treatment of A20 cells before or after PPD 
pulsing had not effect on their stimulatory capacity. These results substantiate the 
conclusion that P388Dl cells must internalize and probably catabolize PPD to form 
the relevant antigenic determinant. A20 cells, on the other hand, may not need to 
internalize PPD to form the determinant recognized by the T cells. 
Since A20 cells apparently did not require PPD internalization for stimulation, it 
was important to determine if T-cell stimulation could be produced with isolated A20 
plasma membranes. In the past, isolated membranes alone have not directly stimulated 
T cells and always required reprocessing by APC in the culture. To our surprise, we 
found that isolated plasma membranes from A20 cells failed to stimulate the T hy- 
bridomas in the presence of PPD (Table 5). However, the membranes from PPD- 
pulsed A20 cells successfully stimulated T hybridomas in the absence of soluble PPD 
and any other stimulator cells. In titration experiments it was found that almost 10 
times as many cell equivalents of membranes as intact A20 cells were required to 
obtain the same level of IL-2 production (data not shown). It should also be noted 
that addition of soluble PPD to the mixture of T hybridomas and membranes from 
PPD-pulsed A20 cells did not enhance the stimulation. The stimulation of the PPD- 
specific T hybridomas by the membranes was also specific for PPD since membranes 
from untreated A20 cells or from A20 cells that were pulsed with another antigen 
(N-hydroxysuccinimidyl-4azidobenzoate) failed to stimulate the PPD-specific T hy- 
brdiomas (data not shown). Stimulation of T hybridomas by plasma membranes from 
PPD-pulsed A20 cells was also restricted by I-Ad, and the T cell responses were effec- 
tively blocked by addition of anti-Iad monoclonal antibody, M5/114.15.2 (19), to the 
mixture of T hybridoma and PPD-pulsed plasma membranes, as shown in Table 6. 
As a control, the anti-Iak monoclonal antibody, 10.2.16 (20), gave no significant in- 
hibition of the T hybridoma response. Thus, antigen-specific T-cell stimulation by 
TABLE 4 
Ability of Chloroquine-Treated Cells to Stimulate T Hybridoma Cells 
IL-2 units/ml 
Chloroquine treatment 
Before PPD After PPD No 
Cell type pulsing” pulsing” treatment 
A20 640 640 640 
Ia-positive P388Dl 80 320 640 
a A20 or Ia-positive P388D I cells were incubated at 37°C with 600 &f chloroquine for 45 min, washed, 
and then incubated with 200 &ml PPD for 2 hr at 37°C washed, and added to T hybridomas for 
stimulation. 
b A20 or Ia-positive P388Dl cells were incubated with 200 &ml of PPD for 2 hr at 37°C washed, and 
then incubated with 600 M chloroquine for 45 min at 37’C, washed, and added to T hybridomas for 
stimulation. 
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TABLE 5 
Comparison of the Ability of Plasma Membranes from Antigen-Pulsed A20.2JAD and from 
Non-antigen-Pulsed A20.2JAD to Stimulate T Hybridoma Cells 
Source of Presence of 







’ Plasma membranes (3 X lo6 cell equivalents) prepared from PPD-pulsed or non-antigen-pulsed A20 
cells were cultured with the PPD-specific T hybridoma cells with or without 10 pg soluble PPD, and the 
IL-2 responses were determined as described under Materials and Methods. 
isolated plasma membranes is regulated by Ia antigens similar to stimulation by intact 
antigen-presenting cells. 
One of the puzzling features of the T-cell stimulation by isolated membranes is that 
addition of soluble PPD to membranes from non-antigen-pulsed A20 cells failed to 
stimulate. Since PPD added to glutaraldehyde-fixed A20 cells resulted in excellent 
T-cell responses, we anticipated that membranes with added PPD would be stimulatory. 
The first possibility we considered was that the membranes failed to proteolytically 
process PPD, perhaps since PMSF was included in the isolation buffer that would 
have blocked some proteases. We therefore prepared membranes in the absence of 
PMSF, but they too failed to stimulate T cells when soluble PPD was added. In other 
approaches, we predigested PPD with trypsin, chymotrypsin, and supernatant fluids 
from A20 cell cultures, then added the digested PPD to membranes and T cells, but 
no stimulation was observed. Supernatant fluids from A20 cells cultured with PPD, 
and presumably containing processed PPD, were also tried without success. In addition, 
NP40-solubilized extracts of the PPD-pulsed A20 membranes were also nonstimu- 
latory, even in the presence of intact A20 cells. We therefore conclude that the mem- 
brane preparation disrupts some processing elements, or that molecular associations 
between processed PPD and other membrane structures does not occur after the A20 
cells are disrupted. Thus, while presentation of PPD does not seem to require inter- 
nalization by A20 cells, the integrity of the plasma membrane is critical for presentation. 
TABLE 6 
Effect of Anti-Ia Antibodies on the Ability of Antigen-Pulsed Plasma Membranes 









’ Anti-Ia antibodies (20% final volume of monoclonal antibody-containing supematant fluids) were added 
to cultures of PPD-specific T hybridoma cells and plasma membranes (2 X lo6 cell equivalents) from PPD- 
pulsed A20.2JAD cells, and the IL-2 responses were determined as described under Materials and Methods. 
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DISCUSSION 
Many reports have described an antigen-processing event that apparently involves 
the internalization and catabolism of protein antigens. Thus, antigen-presenting cells 
fixed with glutaraldehyde or paraformaldehyde fail to present protein antigens for 
T-cell activation unless the protein is first digested to a smaller antigenic fragment 
( 1,2). In this report we have shown that protein antigen presented to the same T cells 
by two different presenting cells shows different pathways in forming the antigenic 
determinant. According to the interpretation that sensitivity to glutaraldehyde fixation 
indicates a requirement for antigen internalization, this would suggest that the pro- 
cessing of PPD by P388Dl cells involves internalization, whereas processing by A20 
cells does not. This conclusion was substantiated by the finding that chloroquine 
inhibited antigen processing by P388Dl cells, presumably by inhibiting lysosomal 
catabolism ( 14, 15) but had no effect on antigen presentation by A20 cells. Thus, the 
processing pathway by P388Dl cells is similar to that described in other systems 
(1-5) that indicate that protein antigens are internalized and degraded by lysosomal 
enzymes to produce antigenic peptide fragments that become associated with the 
plasma membrane. This latter point was substantiated by finding that glutaraldehyde 
treatment of P388Dl cells after PPD pulsing had no inhibitory effect indicating that 
the relevant antigenic moiety was displayed on the cell surface, consistent with similar 
results by others (1, 2). 
By contrast with the results described above for the antigen processing by P388Dl 
cells, PPD presentation by A20 cells was not impaired by glutaraldehyde fixation and 
chloroquine treatment. These results indicate that A20 cells process and present PPD 
by a pathway that is different from that utilized by P388Dl cells. However, the same 
antigenic determinant must be produced by both cellular processing pathways since 
only a single determinant is recognized by the monoclonal T cell. The implications 
of these results with A20 cells are that either (i) PPD requires no processing for pre- 
sentation to T cells, as suggested in a recent report by Kaye et al. (16), or (ii) A20 cells 
can process PPD via a membrane-bound mechanism. Assuming that processing is 
required for presentation of PPD, as indicated by the results with P388D1, the most 
likely possibility is that in A20 cells the moieties responsible for processing of PPD 
are located in the plasma membrane. Since the major processing event appears to be 
antigen catabolism to smaller peptide fragments, it is likely that this results from a 
membrane-bound protease. Thereby the relevant antigenic peptide results from pro- 
teolysis by an enzyme, or enzymes, that are associated with the A20 membrane, but 
are internal (lysosomal) in P388Dl cells. This indicates that there are several different 
cellular processing pathways that can be used to create the relevant antigen from a 
larger protein. These mechanisms may vary from one to another type of antigen- 
presenting cell for formation of the same antigenic determinants, and potentially could 
also serve to create antigenic determinants from foreign proteins that are unique for 
each antigen-presenting cell type, as previously suggested (17). It should be pointed 
out, however, that these results may be unique to the PPD system examined here, 
and may not be generally applicable to all protein antigens and APC. 
As indicated before, the fact that glutaraldehyde-treated A20 cells could still present 
PPD to T hybridomas was an indication that it may be possible to achieve stimulation 
with isolated plasma membranes. Indeed, it was found that membranes from PPD- 
pulsed A20 cells were competent to stimulate T hybridoma cells, and that this stim- 
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ulation involved antigen and class II MHC antigens as does stimulation by intact cells. 
In most systems it has been possible to achieve stimulation by isolated membranes 
only in the presence of viable APC, which has been interpreted as an indication that 
the membranes were being reprocessed by APC for T-cell presentation. Clearly this 
is not the case in the membrane stimulation described in this report since no stimulator 
cells are present with the T hybridoma cells, which themselves fail to present PPD 
and do not express class II MHC antigens (unpublished observations). Very recently, 
however, Watts et al. ( 18) have shown that purified class II MHC antigens incorporated 
into synthetic planar membranes will stimulate T hybridomas in the presence of large 
amounts of soluble antigen. In this sytem the observed stimulation was relatively 
weak, and they did not determine if antigen pulsing of the planar membranes could 
stimulate the T cells. Another feature to point out is that in our hands antigen-pulsed 
membranes do not stimulate in all antigen specific T-cell hybridoma systems we have 
examined, and thus far is most efficient with the PPD-specific T hybrid described 
here. One of the puzzling aspects of the results described above is that glutaraldehyde- 
treated A20 cells can present PPD, whereas addition of PPD to isolated membranes 
and T cells is nonantigenic. One would anticipate that if PPD-processing by A20 cells 
is a membrane-associated event, then isolated plasma membranes would be able to 
process and present PPD. It was observed, however, that only membranes from PPD- 
pulsed A20 cells would stimulate T cells. Attempts were made to preprocess the PPD 
before adding it to culture with A20 membranes, but all of these were unsuccessful. 
The simplest explanation for this is that the processing moieties are destroyed during 
the membrane isolation procedure. Alternatively, the processing system could exist 
as a multimolecular complex that is disrupted during isolation. Experiments to in- 
vestigate these possibilities are currently in progress. 
In summary, the results reported here show that two different antigen-presenting 
cells differ in the cellular location of the antigen processing event required for T-cell 
antigen recognition of the protein antigen PPD. This is an observation with important 
implications for the ability of different cells to act as antigen-presenting cells, and 
raises the possibility that different antigen-presenting cell types can produce unique 
peptide antigens from a larger protein which may selectively activate distinct T-cell 
subpopulations. At this time it is not yet known if this applies to all protein antigens, 
or is unique to the PPD system examined here. The second important observation 
reported here is the ability of isolated plasma cell membranes from antigen-pulsed 
APC to directly stimulate T cells. This is the first report of direct T-cell stimulation 
by isolated antigen-pulsed membranes in the clear absence of stimulator cells, to our 
knowledge, and thereby provides a starting point to more carefully define the formation 
of the antigenic determinants specifically recognized by T cells. 
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